Sectoral Asset Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-128,300
Closed -$1.31M 116
2018
Q4
$1.31M Sell
128,300
-481,312
-79% -$6.16M 0.18% 61
2018
Q3
$10.2M Sell
609,612
-429,288
-41% -$7.76M 1.08% 35
2018
Q2
$16.4M Buy
1,038,900
+175,300
+20% +$2.66M 1.84% 23
2018
Q1
$11M Buy
+863,600
New +$12.5M 1.2% 30
2017
Q2
Sell
-713,119
Closed -$14.8M 70
2017
Q1
$14.8M Buy
713,119
+43,768
+7% +$969K 1.73% 24
2016
Q4
$13.9M Buy
669,351
+132,230
+25% +$3.44M 1.54% 25
2016
Q3
$17.6M Buy
537,121
+11,900
+2% +$362K 1.73% 26
2016
Q2
$13.1M Sell
525,221
-765,932
-59% -$20.7M 1.35% 28
2016
Q1
$31.6M Buy
1,291,153
+356,202
+38% +$8.25M 1.53% 20
2015
Q4
$30.9M Buy
934,951
+172,269
+23% +$5.83M 1.32% 23
2015
Q3
$25M Buy
762,682
+79,946
+12% +$3.4M 1.14% 24
2015
Q2
$36.2M Sell
682,736
-389,701
-36% -$14.2M 1.51% 20
2015
Q1
$31M Buy
1,072,437
+968,137
+928% +$26.6M 1.18% 29
2014
Q4
$3.03M Buy
104,300
+15,000
+17% +$269K 0.14% 54
2014
Q3
$1.13M Buy
89,300
+48,775
+120% +$737K 0.05% 63
2014
Q2
$813K Buy
+40,525
New +$571K 0.03% 61

Other funds holding ALDR

Sectoral Asset Management's ALDR Position: Q1 2019 in Review

Sectoral Asset Management sold out of Alder Biopharmaceuticals (ALDR) in Q1 2019, closing a stake of 128,300 shares — an estimated $1.31M sold.

Sectoral Asset Management first reported a position in ALDR in Q2 2014 and held it in 16 quarters. The position peaked at $36.2M in Q2 2015. 123 funds tracked by Wall St. Rank hold ALDR as of Q1 2019.

  • Sectoral Asset Management reported no remaining Alder Biopharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Sectoral Asset Management sold 128,300 Alder Biopharmaceuticals shares in Q1 2019, an estimated $1.31M.
  • Sectoral Asset Management first reported a position in Alder Biopharmaceuticals in Q2 2014 and held it in 16 quarters.
  • Sectoral Asset Management's Alder Biopharmaceuticals position peaked at $36.2M in Q2 2015.
  • 123 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q1 2019.

Based on Sectoral Asset Management's 13F filing for Q1 2019, filed 14 May 2019.